From hero to zero: Uruguay's coronavirus boomerang
US pulls back on charge Switzerland, Vietnam manipulate currency
The shooter took his own life when police entered the building. Five others were injured, one critically. It's the third mass shooting this year in Indianapolis.
The New York Yankees and Atlanta Braves have played very poorly through the first two weeks of the 2021 MLB season.
Budweiser, Miller Lite, Samuel Adams and several other businesses are offering perks and incentives to encourage Americans to get the COVID vaccine.
Pakistan orders temporary social media shutdown after violent protests
US homebuilding rebounds sharply in March from storm-caused plunge
Vaccine giant tweets Biden to end US raw materials 'embargo'
No vaccine is 100% effective, which is why the vaccine breakthrough cases are not unexpected by the CDC.
Blood clots are clumps of blood that have turned into a gel-like substance. Blood clotting is necessary to prevent a person from losing too much blood caused by injuries, but when does it become dangerous?
Greensill: what's what in scandal rocking UK politics
Asia's richest man Mukesh Ambani is sending oxygen produced at his refineries to help India in battling a deadly second wave of coronavirus.
WHO 'very concerned' as virus numbers climb in PNG
Indonesian hackers arrested over $60 million US Covid-19 scam
Top seer at India religious mega-festival dies from Covid-19
France says 'highly probable' EU won't renew AZ orders
News of the man's condition follows Tuesday's announcement that a pause has been placed on the distribution of Johnson & Johnson's vaccine due to cases of blood-clotting.
Lille, wounded Bayern and cup do-over - what to watch in Europe
Case numbers have risen significantly in 2021, but Korea provided a blueprint in 2020 for how to best deal with the coronavirus.
Biden's broadside against Russia came the same week as he offered to meet President Vladimir Putin for their first summit.
Some are calling out Trump for not doing more in regards to the pandemic last year.
Pfizer CEO: Vaccine third dose 'likely' needed within 12 months